GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » Cash Receipts from Operating Activities

Mach7 Technologies (ASX:M7T) Cash Receipts from Operating Activities : A$31.10 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies Cash Receipts from Operating Activities?

Mach7 Technologies's Cash Receipts from Operating Activities for the six months ended in Dec. 2023 was A$15.48 Mil.

Mach7 Technologies's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was A$31.10 Mil.


Mach7 Technologies Cash Receipts from Operating Activities Historical Data

The historical data trend for Mach7 Technologies's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies Cash Receipts from Operating Activities Chart

Mach7 Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.34 17.18 21.79 28.17 24.57

Mach7 Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.99 16.18 8.95 15.62 15.48

Mach7 Technologies Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$31.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mach7 Technologies Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Mach7 Technologies (ASX:M7T) Business Description

Traded in Other Exchanges
N/A
Address
120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines